Stock FNCH FINCH THERAPEUTICS GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Finch Therapeutics Group, Inc.

Equities

FNCH

US31773D2009

Delayed Nasdaq
Other stock markets
 03:20:07 2024-04-29 pm EDT 		5-day change 1st Jan Change
2.3 USD -0.86% Intraday chart for Finch Therapeutics Group, Inc. -0.43% -36.29%
Mar. 25 Finch Therapeutics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 12 Top Premarket Decliners MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Initiates Finch Therapeutics Group at Buy With $17 Price Target
MT
Jefferies Adjusts Finch Therapeutics Group's Price Target to $17 From $29, Maintains Buy Rating
MT
FINCH THERAPEUTICS : Jefferies Initiates Finch Therapeutics at Buy Rating With $29 Price Target
MT
FINCH THERAPEUTICS : Evercore ISI Starts Finch Therapeutics Group at Outperform With $34 Price Target
MT
FINCH THERAPEUTICS : BofA Securities Initiates Coverage on Finch Therapeutics Group With Buy Rating, $25 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FNCH Stock
  4. News Finch Therapeutics Group, Inc.
  5. Analyst Reco.